Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125336963 | 12533696 | 3 | F | 2016 | 20160714 | 20160706 | 20160727 | EXP | US-ABBVIE-16K-163-1667522-00 | ABBVIE | 48.64 | YR | F | Y | 90.80000 | KG | 20160727 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125336963 | 12533696 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 1056664 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 125336963 | 12533696 | 2 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | U | UNKNOWN | 0 | 10 | MG | QD | ||||||
| 125336963 | 12533696 | 3 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | U | UNKNOWN | 0 | 20 | MG | |||||||
| 125336963 | 12533696 | 4 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | U | UNKNOWN | 0 | 50 | MG | |||||||
| 125336963 | 12533696 | 5 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | U | UNKNOWN | 0 | 75 | MG | |||||||
| 125336963 | 12533696 | 6 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | U | UNKNOWN | 0 | 50 | MG | |||||||
| 125336963 | 12533696 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 125336963 | 12533696 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 125336963 | 12533696 | 9 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125336963 | 12533696 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 125336963 | 12533696 | 11 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125336963 | 12533696 | 1 | Rheumatoid arthritis |
| 125336963 | 12533696 | 2 | Migraine |
| 125336963 | 12533696 | 7 | Rheumatoid arthritis |
| 125336963 | 12533696 | 8 | Product used for unknown indication |
| 125336963 | 12533696 | 9 | Rheumatoid arthritis |
| 125336963 | 12533696 | 10 | Fibromyalgia |
| 125336963 | 12533696 | 11 | Dyspepsia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125336963 | 12533696 | HO |
| 125336963 | 12533696 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125336963 | 12533696 | Dysarthria | |
| 125336963 | 12533696 | Fall | |
| 125336963 | 12533696 | Gait disturbance | |
| 125336963 | 12533696 | Headache | |
| 125336963 | 12533696 | Intracranial aneurysm | |
| 125336963 | 12533696 | Laceration | |
| 125336963 | 12533696 | Migraine | |
| 125336963 | 12533696 | Mobility decreased | |
| 125336963 | 12533696 | Musculoskeletal chest pain | |
| 125336963 | 12533696 | Nausea | |
| 125336963 | 12533696 | Post-traumatic pain | |
| 125336963 | 12533696 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125336963 | 12533696 | 1 | 201601 | 201606 | 0 | |
| 125336963 | 12533696 | 2 | 201508 | 0 | ||
| 125336963 | 12533696 | 3 | 2015 | 201606 | 0 | |
| 125336963 | 12533696 | 4 | 201606 | 201606 | 0 | |
| 125336963 | 12533696 | 5 | 20160628 | 201607 | 0 | |
| 125336963 | 12533696 | 6 | 201607 | 0 |